loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 203560 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Actavis Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ACTAVIS ELIZABETH (3)

    filter

    01 TABLET, FOR SUSPENSION;ORAL (3)

    filter

    01 RX (3)

    filter

    01 DEFERASIROX (3)

    filter

    01 No (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DEFERASIROX

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, FOR SUSPEN...
    500MG
    2016-01-26
    203560
    DEFERASIROX
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DEFERASIROX

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, FOR SUSPEN...
    125MG
    2016-01-26
    203560
    DEFERASIROX
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DEFERASIROX

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, FOR SUSPEN...
    250MG
    2016-01-26
    203560
    DEFERASIROX
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 203560

    Looking for FDA Orange Book APPLICATION 203560 3

    19

    Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is DEFERASIROX, with a corresponding application number 203560.

    Regulatory Information RX

    With a dosage strength 500MG

    Dosage Form Route TABLET, FOR SUSPENSION; ORAL

    Reference Listed Drug No

    Approved since 2016-01-26

    Therapeutic Equivalence (TE) Code AB

    18

    Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is DEFERASIROX, with a corresponding application number 203560.

    Regulatory Information RX

    With a dosage strength 125MG

    Dosage Form Route TABLET, FOR SUSPENSION; ORAL

    Reference Listed Drug No

    Approved since 2016-01-26

    Therapeutic Equivalence (TE) Code AB

    17

    Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is DEFERASIROX, with a corresponding application number 203560.

    Regulatory Information RX

    With a dosage strength 250MG

    Dosage Form Route TABLET, FOR SUSPENSION; ORAL

    Reference Listed Drug No

    Approved since 2016-01-26

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY